Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
比较0.1%溴芬酸钠和0.1%吡嘧司特钾治疗过敏性结膜炎的疗效。
2
OBJECTIVE a RP-HPLC method for the determination of pemirolast potassium and its related compounds in tablets was developed to control the quality of pemirolast potassium preparations.
Clinical studies suggest that pemirolast potassium can prevent and cure variation asthma, anaphylactic rhinitis, anaphylactic conjunctivitis and atopic dermatitis with little untoward reactions.